U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT06306118) titled 'Autoguide Positioning Device for Multiple Stereotactic Biopsies' on Nov. 7, 2023.
Brief Summary: The purpose of this clinical study should be that, in the context of planned resections of glial brain tumors, pieces of tissue (biopsies) are removed from the tumor at several specific locations before the actual tumor resection takes place.
The aim of these biopsies in advance to the actual tumor resection will be to receive tumor tissue samples not altered in such a way that it is no longer adequate for further treatment. If not adequate, a so-called "undergrading" could occur, which means that the biological structure of the tumor ...